What is Rocket Doctor AI Inc.'s (AIDR.CN) StockRank?

MoatMap's StockRank for Rocket Doctor AI Inc. (AIDR.CN) is 6/100, with a Strong Sell signal. This is a composite score combining Quality (16), Value (20), and Momentum (42) factor ranks across MoatMap's 20,000+ stock universe.

Does Rocket Doctor AI Inc. have an economic moat?

Rocket Doctor AI Inc. (AIDR.CN) has a Quality factor score of 16/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Rocket Doctor AI Inc. a buy, hold, or sell?

MoatMap's current signal for Rocket Doctor AI Inc. (AIDR.CN) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Rocket Doctor AI Inc. in?

Rocket Doctor AI Inc. (AIDR.CN) operates in the Healthcare sector, specifically the Health Information Services industry (Canada).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

AIDR.CN

STRONG SELLREMOVE

Rocket Doctor AI Inc. · Healthcare · Canada · $42M · Avg Vol: $91K/d

StockRank

P/E (TTM)

—

ROE

—

D/E

0.5x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Rocket Doctor AI is a micro-cap telehealth platform lacking a sustainable economic moat or path to scale. It is highly speculative and fails our rigorous quality and liquidity requirements.

COMPANY DESCRIPTION

Rocket Doctor AI Inc. operates a digital health platform that connects patients with licensed physicians for virtual medical consultations, integrated with advanced AI-driven diagnostic tools. The company's platform streamlines clinical workflows, automates administrative tasks, and improves patient triage efficiency. Rocket Doctor's scalable B2B and B2C models address the growing demand for accessible, cost-effective telehealth solutions in North America.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	0	0	7,756	1.2M	15725.5%
EPS	-0.03	-0.07	-0.12	-0.08	—
Shares	96.9M	96.9M	51.2M	85.4M	-11.8%
Debt	0.4M	0.4M	0.1M	0.3M	-9.8%
Equity	-1.5M	-0.5M	0.6M	2.5M	343.0%
Op CF	-1.0M	-0.5M	-3.1M	-4.6M	—
Inv CF	—	—	0	-1.0M	—
Fin CF	0.4M	1.0M	3.5M	5.2M	—

PRICE (1Y)+1.7%

SMA 50SMA 200

$0.42

RSI (14)

57.1

52W High

$0.69

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-187.0%2.2

ROE

—N/A

GP/Assets

0.2%10.9

Op. Margin

-5080.2%3.5

FCF/Assets

-9.4%28.7

Piotroski

321.5

Int. Cover

-50.0x6.1

D/E Ratio

0.46x33.5

Current Ratio

0.61x3.0

Value

P/E (TTM)

—N/A

EV/EBITDA

—N/A

P/FCF

—N/A

P/B

22.2x4.5

P/S

1803.9x2.3

Div Yield

—N/A

Momentum

52W High %

61%45.7

RS 6M

-20%53.0

SMA 50/200

0.89x32.5

EPS Rev 4W

-83.2%0.1

EPS Rev 12W

—N/A

EPS Improve

+43%50.7

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$42M

P/E (Forward)

-5.5x

Gross Margin

63.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AIDR.CN are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
AIDR.CN	Rocket Doctor AI Inc.(you)	$42M	6	STRONG SELL
VST.CN	Victory Square Technologies Inc.	$51M	55	HOLD
QNTM.CN	Quantum BioPharma Ltd.	$45M	2	STRONG SELL
ZEN.V	Zentek Ltd.	$50M	1	STRONG SELL
TLT.V	Theralase Technologies Inc.	$45M	13	STRONG SELL
PINK.V	Perimeter Medical Imaging AI, Inc.	$30M	9	STRONG SELL
BLO.CN	Cannabix Technologies Inc.	$58M	11	STRONG SELL
MDNA.TO	Medicenna Therapeutics Corp.	$27M	1	STRONG SELL
OPTI.CN	Optimi Health Corp.	$25M	2	STRONG SELL
EDSA	Edesa Biotech, Inc.	$61M	17	STRONG SELL

Peer medians: ROE -44.7% · P/E 14.3x · Gross margin 32.9%

Rocket Doctor AI Inc. (AIDR.CN) — Stock Score Summary

Rocket Doctor AI Inc. (AIDR.CN) has a MoatMap StockRank of 6/100 based on Quality (16/100), Value (20/100), and Momentum (42/100) factor scores. The current signal is STRONG SELL. Rocket Doctor AI is a micro-cap telehealth platform lacking a sustainable economic moat or path to scale. It is highly speculative and fails our rigorous quality and liquidity requirements.

Key Financial Metrics

Price	$0.42
Market Cap	$42M
P/E (Forward)	-5.46
Price/Book	22.19
Return on Invested Capital	-187.0%
Debt/Equity	46.41
Gross Margin	63.4%
Operating Margin	-5080.2%
Free Cash Flow	$-734K

Rocket Doctor AI Inc. operates in the Health Information Services industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Rocket Doctor AI Inc.’s (AIDR.CN) StockRank?: MoatMap’s StockRank for Rocket Doctor AI Inc. (AIDR.CN) is 6/100, with a Strong Sell signal. It is a composite of Quality (16), Value (20), and Momentum (42) factor ranks across MoatMap’s 20,000+ stock universe.
Does Rocket Doctor AI Inc. have an economic moat?: Rocket Doctor AI Inc. (AIDR.CN) has a Quality factor score of 16/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Rocket Doctor AI Inc. a buy, hold, or sell?: MoatMap’s current signal for Rocket Doctor AI Inc. (AIDR.CN) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Rocket Doctor AI Inc. in?: Rocket Doctor AI Inc. (AIDR.CN) operates in the Healthcare sector, specifically the Health Information Services industry (Canada).